Bank of America’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.2M | Sell |
375,232
-121,693
| -24% | -$1.69M | ﹤0.01% | 3431 |
|
|
2025
Q4 | $6.98M | Buy |
496,925
+88,884
| +22% | +$1.25M | ﹤0.01% | 3121 |
|
|
2025
Q3 | $5.7M | Sell |
408,041
-461,848
| -53% | -$6.65M | ﹤0.01% | 3862 |
|
|
2025
Q2 | $13.1M | Sell |
869,889
-1,106,473
| -56% | -$15.8M | ﹤0.01% | 2970 |
|
|
2025
Q1 | $26.1M | Buy |
1,976,362
+59,937
| +3% | +$827K | ﹤0.01% | 2178 |
|
|
2024
Q4 | $30.3M | Sell |
1,916,425
-2,377,780
| -55% | -$35.7M | ﹤0.01% | 1911 |
|
|
2024
Q3 | $68.2M | Buy |
4,294,205
+37,600
| +0.9% | +$605K | 0.01% | 1319 |
|
|
2024
Q2 | $64.9M | Sell |
4,256,605
-201,645
| -5% | -$2.89M | 0.01% | 1282 |
|
|
2024
Q1 | $65.4M | Buy |
4,458,250
+1,645,485
| +59% | +$24M | 0.01% | 1297 |
|
|
2023
Q4 | $39.1M | Sell |
2,812,765
-43,775
| -2% | -$585K | ﹤0.01% | 1544 |
|
|
2023
Q3 | $38.2M | Buy |
2,856,540
+132,960
| +5% | +$1.8M | ﹤0.01% | 1465 |
|
|
2023
Q2 | $34.4M | Buy |
2,723,580
+149,600
| +6% | +$1.75M | ﹤0.01% | 1591 |
|
|
2023
Q1 | $29.3M | Buy |
2,573,980
+2,343,425
| +1,016% | +$25.3M | ﹤0.01% | 1783 |
|
|
2022
Q4 | $2.39M | Buy |
230,555
+9,020
| +4% | +$97.3K | ﹤0.01% | 4095 |
|
|
2022
Q3 | $2.32M | Sell |
221,535
-360
| -0.2% | -$3.83K | ﹤0.01% | 4132 |
|
|
2022
Q2 | $2.46M | Buy |
221,895
+4,775
| +2% | +$51.9K | ﹤0.01% | 4125 |
|
|
2022
Q1 | $2.42M | Sell |
217,120
-819,160
| -79% | -$9.29M | ﹤0.01% | 4412 |
|
|
2021
Q4 | $13.6M | Sell |
1,036,280
-497,080
| -32% | -$6.27M | ﹤0.01% | 2609 |
|
|
2021
Q3 | $20M | Sell |
1,533,360
-527,530
| -26% | -$7.03M | ﹤0.01% | 2178 |
|
|
2021
Q2 | $30.3M | Buy |
2,060,890
+128,385
| +7% | +$1.8M | ﹤0.01% | 1767 |
|
|
2021
Q1 | $23.7M | Buy |
1,932,505
+250,815
| +15% | +$3.22M | ﹤0.01% | 1899 |
|
|
2020
Q4 | $24M | Buy |
1,681,690
+171,670
| +11% | +$2.31M | ﹤0.01% | 1717 |
|
|
2020
Q3 | $21M | Buy |
1,510,020
+95,075
| +7% | +$1.13M | ﹤0.01% | 1665 |
|
|
2020
Q2 | $15M | Sell |
1,414,945
-166,575
| -11% | -$1.69M | ﹤0.01% | 1853 |
|
|
2020
Q1 | $12.8M | Buy |
1,581,520
+366,610
| +30% | +$3.06M | ﹤0.01% | 1853 |
|
|
2019
Q4 | $9.86M | Buy |
1,214,910
+249,410
| +26% | +$1.97M | ﹤0.01% | 2568 |
|
|
2019
Q3 | $7.32M | Buy |
965,500
+23,060
| +2% | +$172K | ﹤0.01% | 2829 |
|
|
2019
Q2 | $7.06M | Buy |
942,440
+9,295
| +1% | +$73.1K | ﹤0.01% | 2890 |
|
|
2019
Q1 | $7.56M | Buy |
933,145
+867,850
| +1,329% | +$6.59M | ﹤0.01% | 2752 |
|
|
2018
Q4 | $493K | Buy |
65,295
+21,555
| +49% | +$152K | ﹤0.01% | 4937 |
|
|
2018
Q3 | $302K | Buy |
43,740
+2,450
| +6% | +$16.4K | ﹤0.01% | 5257 |
|
|
2018
Q2 | $266K | Buy |
41,290
+7,120
| +21% | +$44.9K | ﹤0.01% | 5248 |
|
|
2018
Q1 | $225K | Sell |
34,170
-209,225
| -86% | -$1.47M | ﹤0.01% | 5307 |
|
|
2017
Q4 | $1.83M | Buy |
243,395
+180,835
| +289% | +$1.3M | ﹤0.01% | 4034 |
|
|
2017
Q3 | $446K | Sell |
62,560
-292,915
| -82% | -$2.11M | ﹤0.01% | 5025 |
|
|
2017
Q2 | $3M | Sell |
355,475
-49,980
| -12% | -$406K | ﹤0.01% | 3520 |
|
|
2017
Q1 | $3.26M | Sell |
405,455
-36,320
| -8% | -$314K | ﹤0.01% | 3436 |
|
|
2016
Q4 | $4M | Sell |
441,775
-110
| -0% | -$1.02K | ﹤0.01% | 3147 |
|
|
2016
Q3 | $4.1M | Buy |
441,885
+110,510
| +33% | +$1.06M | ﹤0.01% | 3006 |
|
|
2016
Q2 | $3.4M | Buy |
331,375
+70,195
| +27% | +$643K | ﹤0.01% | 3155 |
|
|
2016
Q1 | $2.36M | Sell |
261,180
-652,835
| -71% | -$5.84M | ﹤0.01% | 3426 |
|
|
2015
Q4 | $8.46M | Buy |
914,015
+477,735
| +110% | +$5.23M | ﹤0.01% | 2430 |
|
|
2015
Q3 | $5.58M | Buy |
436,280
+213,715
| +96% | +$2.65M | ﹤0.01% | 2779 |
|
|
2015
Q2 | $2.46M | Buy |
222,565
+85,555
| +62% | +$945K | ﹤0.01% | 3265 |
|
|
2015
Q1 | $1.56M | Sell |
137,010
-238,370
| -64% | -$2.53M | ﹤0.01% | 3450 |
|
|
2014
Q4 | $3.79M | Buy |
375,380
+234,510
| +166% | +$2.47M | ﹤0.01% | 2806 |
|
|
2014
Q3 | $1.48M | Sell |
140,870
-229,075
| -62% | -$2.15M | ﹤0.01% | 3651 |
|
|
2014
Q2 | $3.19M | Sell |
369,945
-185,400
| -33% | -$1.56M | ﹤0.01% | 2954 |
|
|
2014
Q1 | $4.88M | Buy |
555,345
+261,755
| +89% | +$2.28M | ﹤0.01% | 2418 |
|
|
2013
Q4 | $2.41M | Buy |
293,590
+5,275
| +2% | +$41.8K | ﹤0.01% | 3141 |
|
|
2013
Q3 | $2.18M | Buy |
288,315
+181,790
| +171% | +$1.32M | ﹤0.01% | 3190 |
|
|
2013
Q2 | $806K | Buy |
+106,525
| New | +$778K | ﹤0.01% | 4258 |
|
Other funds holding RDY
AIM
Bank of America's RDY Position: Q1 2026 in Review
Bank of America reduced its Dr. Reddy's Laboratories (RDY) stake by 24% in Q1 2026, selling an estimated $1.69M and leaving 375,232 shares worth $5.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3431.
Bank of America first reported a position in RDY in Q2 2013 and has held it in 52 quarters since. The position peaked at $68.2M in Q3 2024. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.
- Bank of America held 375,232 shares of Dr. Reddy's Laboratories worth $5.2M as of Q1 2026.
- Bank of America sold 121,693 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $1.69M.
- Dr. Reddy's Laboratories made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3431 holding.
- Bank of America first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Dr. Reddy's Laboratories position peaked at $68.2M in Q3 2024.
- 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.